Recurrent GBM brain tumors with few mutations respond best to immunotherapy
The finding from a genetic analysis of tumors treated with Duke’s poliovirus therapy suggests a predictive biomarker for survival.
The Drug Guy Changes Course
After a scientific meeting in New Hampshire 2017, breast cancer researcher Donald McDonnell, PhD, met his wife, Mary, in M
“Everything Reminds Me of a Story:” Nobel Laureate Bob Lefkowitz, MD, publishes memoir
You can’t grow up in the Bronx, enter medical school at age 19, serve as a Yellow Beret for the National Institutes of Health (NIH), discover one of the most therapeutically accessible proteins in
Congrats 2021 Duke Clinical Leadership Program cohort!
The School of Medicine Office for Faculty is pleased to announce the 2021 DCLP participants.
Physician-scientist takes the long view and sets her sights high
Dr. Bryan Batch, a Duke endocrinologist and researcher, studies treating metabolic disorders (like diabetes) with non-pharmacological approaches.
LATIN-19 Co-founders discuss COVID-19's impact on the Latinx community
Duke University School of Medicine Dean Mary E. Klotman, MD, talks with co-founders of Duke’s LATIN-19 initiative Viviana S.
Duke researchers uncover pathway in lung cancer brain metastasis
A Duke research team has identified a molecular process by which lung cancer cells metastasize and become cancers in the brain.
Palliative care improves quality of life for patients with leukemia
Integrating palliative care early in the course of cancer therapy for patients with advanced acute myeloid leukemia (AML) resulted in substantial improvements in patients’ quality of life, mood and
Duke faculty & residents respond to COVID-19 among people without housing
Since March, Jacob Feigal, MD, a medical instructor in the Departments of Psychiatry and Medicine, and